Try our beta test site

Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infection

This treatment has been approved for sale to the public.
Sponsor:
Information provided by (Responsible Party):
Cangene Corporation
ClinicalTrials.gov Identifier:
NCT00338442
First received: June 15, 2006
Last updated: April 1, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This treatment has been approved for sale to the public.
  Estimated Study Completion Date: December 2009
  Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)